Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.65 $24.19 Friday, 10th May 2024 PRTA stock ended at $21.34. This is 3.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.46% from a day low at $21.31 to a day high of $22.90.
90 days $19.65 $31.01
52 weeks $19.65 $77.11

Historical Prothena Corporation plc prices

Date Open High Low Close Volume
Mar 21, 2016 $37.25 $42.30 $35.89 $40.62 824 000
Mar 18, 2016 $34.35 $37.69 $33.01 $37.32 1 508 900
Mar 17, 2016 $35.28 $35.78 $32.69 $34.13 591 400
Mar 16, 2016 $35.30 $36.22 $34.12 $35.20 479 600
Mar 15, 2016 $37.50 $37.50 $35.20 $35.58 496 000
Mar 14, 2016 $34.95 $37.98 $34.11 $37.83 462 900
Mar 11, 2016 $34.18 $35.15 $33.53 $35.01 403 600
Mar 10, 2016 $36.16 $37.94 $33.03 $33.66 437 100
Mar 09, 2016 $34.81 $36.16 $33.40 $36.04 578 800
Mar 08, 2016 $37.59 $37.68 $34.50 $34.69 389 600
Mar 07, 2016 $35.94 $39.18 $34.57 $37.90 498 000
Mar 04, 2016 $36.00 $36.73 $34.12 $36.06 471 700
Mar 03, 2016 $35.78 $36.24 $34.10 $36.00 569 700
Mar 02, 2016 $34.20 $36.63 $34.14 $35.90 718 800
Mar 01, 2016 $32.24 $34.49 $30.37 $34.44 677 800
Feb 29, 2016 $34.62 $35.16 $31.67 $31.84 616 600
Feb 26, 2016 $34.07 $35.16 $31.73 $34.76 716 100
Feb 25, 2016 $34.43 $36.50 $33.16 $33.64 797 300
Feb 24, 2016 $32.04 $34.70 $31.50 $34.61 540 600
Feb 23, 2016 $34.65 $35.16 $32.68 $32.81 513 600
Feb 22, 2016 $35.18 $35.80 $34.35 $34.91 453 900
Feb 19, 2016 $29.86 $35.25 $28.29 $34.72 1 340 900
Feb 18, 2016 $34.22 $34.83 $30.82 $31.89 910 300
Feb 17, 2016 $32.29 $34.95 $31.53 $34.25 625 900
Feb 16, 2016 $32.10 $33.14 $30.50 $31.96 423 400
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT